摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-dimethyl-3-naphthalen-1-yloxy-3-(1,3-thiazol-2-yl)propan-1-amine | 116817-65-3

中文名称
——
中文别名
——
英文名称
N,N-dimethyl-3-naphthalen-1-yloxy-3-(1,3-thiazol-2-yl)propan-1-amine
英文别名
——
N,N-dimethyl-3-naphthalen-1-yloxy-3-(1,3-thiazol-2-yl)propan-1-amine化学式
CAS
116817-65-3
化学式
C18H20N2OS
mdl
——
分子量
312.436
InChiKey
VCCLGFCHBNFBEX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    22
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    53.6
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    N,N-dimethyl-3-naphthalen-1-yloxy-3-(1,3-thiazol-2-yl)propan-1-aminesodium hydroxide1,2-丙二醇 作用下, 以 甲苯 为溶剂, 生成 Methyl-[3-(naphthalen-1-yloxy)-3-thiazol-2-yl-propyl]-amine
    参考文献:
    名称:
    Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake
    摘要:
    A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and norepinephrine reuptake. One member of this series, duloxetine (Cymbalta(TM)) has proven to be effective in clinical trials for the treatment of depression. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.08.079
  • 作为产物:
    描述:
    参考文献:
    名称:
    Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake
    摘要:
    A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and norepinephrine reuptake. One member of this series, duloxetine (Cymbalta(TM)) has proven to be effective in clinical trials for the treatment of depression. (C) 2003 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2003.08.079
点击查看最新优质反应信息

文献信息

  • Duloxetine (Cymbalta™), a dual inhibitor of serotonin and norepinephrine reuptake
    作者:F.P. Bymaster、E.E. Beedle、J. Findlay、P.T. Gallagher、J.H. Krushinski、S. Mitchell、D.W. Robertson、D.C. Thompson、L. Wallace、D.T. Wong
    DOI:10.1016/j.bmcl.2003.08.079
    日期:2003.12
    A series of naphthalenyloxy-arylpropylamines have been prepared and are demonstrated to be inhibitors of both serotonin and norepinephrine reuptake. One member of this series, duloxetine (Cymbalta(TM)) has proven to be effective in clinical trials for the treatment of depression. (C) 2003 Elsevier Ltd. All rights reserved.
查看更多